1. Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
   Jihane Boustani et al, 2021, Cancers CrossRef
2. Analysis of Clinical Trials on Therapies for Prostate Cancer in Mainland China and Globally from 2010 to 2020
   Kun Chen et al, 2021, Frontiers in Oncology CrossRef
3. Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%
   Alessio Cortellini et al, 2020, Cancer Immunology, Immunotherapy CrossRef